Shibani Nicum
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Protocol for a global menopause priority setting partnership.
Journal: BMJ open
Published: June 04, 2025
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: May 28, 2025
Corrigendum to "Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study" [Eur J Cancer 222 (2025) 115472].
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 17, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: April 16, 2025
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in England.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 17, 2025
British Gynaecological Cancer Society and British Menopause Society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer.
Journal: Post reproductive health
Published: October 11, 2024
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 02, 2024
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer.
Journal: Future oncology (London, England)
Published: July 31, 2024
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 24, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.
Journal: Cancers
Published: July 16, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: June 11, 2024
Last Updated: 09/26/2026